Pliant Therapeutics, Inc. (PLRX) stock
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.70−0.04 (-5.81%)
Close on Nov 13, 2026Market cap $43.16MP/E –Yield 0.00%
Pliant Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pliant Therapeutics's price to sales ratio was 448.3× on Apr 30, 2024, against 161.0× a year earlier. Over the last 3 years it ranged from 27.9× to 448.3×, with a median of 76.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 448.3× | +142.3 |
| 2023 | Dec 29, 2023 | 306.0× | +209.0 |
| 2022 | Dec 30, 2022 | 97.0× | +48.6 |
| 2021 | Dec 31, 2021 | 48.4× | – |
See a number that looks wrong?